127 related articles for article (PubMed ID: 38031471)
1. Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma-a tertiary cancer center experience.
Mukherjee A; Rainchwar S; Singh A; Halder R; Patra PC; Ahmed R; Bhurani D; Agrawal N
Blood Res; 2023 Dec; 58(4):240-242. PubMed ID: 38031471
[No Abstract] [Full Text] [Related]
2. Nodal Follicular Lymphomas: A Clinicopathological Study from a Tertiary Care Centre in South India.
Supari D; Ananthamurthy A
Indian J Hematol Blood Transfus; 2016 Jun; 32(2):182-5. PubMed ID: 27065580
[TBL] [Abstract][Full Text] [Related]
3. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.
Novelli S; Briones J; Flotats A; Sierra J
Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367
[TBL] [Abstract][Full Text] [Related]
4. [A clinicopathologic study of primary gastric lymphoma of B-cell type among the Japanese with special reference to low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)].
Hayashi K; Motoori T; Nakamura S; Koshikawa T; Nakamura T; Kojima M; Suchi T
Nihon Shokakibyo Gakkai Zasshi; 1993 Dec; 90(12):2985-98. PubMed ID: 8283809
[TBL] [Abstract][Full Text] [Related]
5. Retrospective audit of clinico-pathologic features and treatment outcomes in a cohort of elderly non-Hodgkin's lymphoma patients in a tertiary cancer center.
Nair CK; Patil VM; Raghavan V; Babu S; Nayanar S
Indian J Cancer; 2015; 52(4):541-4. PubMed ID: 26960470
[TBL] [Abstract][Full Text] [Related]
6. Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India.
Das S; Bagal B; Jain H; Kashyap L; Anbarasan S; Abhishek S; Bondili S; Nayak L; Thorat J; Mirgh S; Gokarn A; Punatar S; Ayushi S; Epari S; Tembhare P; Shetty P; Khanna N; Goda J; Aliasgar M; Gupta T; Sengar M; Khattry N; Laskar S; Menon H
Indian J Hematol Blood Transfus; 2023 Jan; 39(1):57-70. PubMed ID: 36699441
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma: experience from a tertiary care center in North India.
Khera R; Jain S; Kumar L; Thulkar S; Vijayraghwan M; Dawar R
Med Oncol; 2010 Jun; 27(2):310-8. PubMed ID: 19350421
[TBL] [Abstract][Full Text] [Related]
8. Histo- and clinico-pathological analysis of a large series of triple-negative breast cancer in a single center in China: Evidences on necessity of histological subtyping and grading.
Zhang S; Huang S; Zhang H; Li D; Li X; Cheng Y; Liu Q; Xu L; Wang Y; Liu Y; Li T
Chin J Cancer Res; 2020 Oct; 32(5):580-595. PubMed ID: 33223753
[TBL] [Abstract][Full Text] [Related]
9. Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia/lymphoma: a report of the second nationwide study of Japan. The T- and B-Cell Malignancy Study Group.
Jpn J Clin Oncol; 1985 Sep; 15(3):517-35. PubMed ID: 2997510
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
[TBL] [Abstract][Full Text] [Related]
11. A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era.
Lim RMH; Chan NPX; Khoo LP; Cheng CL; Tan L; Poon EYL; Somasundaram N; Farid M; Tang TPL; Tao M; Lim ST; Chan JY
Sci Rep; 2020 Mar; 10(1):4373. PubMed ID: 32152442
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related non-Hodgkin's lymphoma: clinico-pathological characteristics and therapeutic strategies (review).
Silvestris N; Crucitta E; Lorusso V; Gamucci T; De Lena M
Int J Oncol; 2002 Mar; 20(3):611-5. PubMed ID: 11836577
[TBL] [Abstract][Full Text] [Related]
13. Inferior survival in high-grade B-cell lymphoma with
McPhail ED; Maurer MJ; Macon WR; Feldman AL; Kurtin PJ; Ketterling RP; Vaidya R; Cerhan JR; Ansell SM; Porrata LF; Nowakowski GS; Witzig TE; Habermann TM
Haematologica; 2018 Nov; 103(11):1899-1907. PubMed ID: 29903764
[TBL] [Abstract][Full Text] [Related]
14. Gastric B-cell mucosa associated lymphoid tissue lymphoma: a clinicopathological study in 56 patients.
Castrillo JM; Montalban C; Obeso G; Piris MA; Rivas MC
Gut; 1992 Oct; 33(10):1307-11. PubMed ID: 1446850
[TBL] [Abstract][Full Text] [Related]
15. Clinico-Pathological Profile of Basaloid Skin Tumors-Experience from a Tertiary Care Center of Eastern India.
Puitandi S; Misra S; Biswas K; Biswas L; Banerjee U
Indian J Surg Oncol; 2023 Sep; 14(3):708-713. PubMed ID: 37900627
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry and scoring of Ki-67 proliferative index and p53 expression in gastric B cell lymphoma from Northern African population: a pilot study.
Zeggai S; Harir N; Tou A; Sellam F; Mrabent MN; Salah R
J Gastrointest Oncol; 2016 Jun; 7(3):462-8. PubMed ID: 27284480
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Pathological Features of Double-Hit and Triple-Hit High-Grade B-Cell Lymphomas: A Retrospective Study from Three Portuguese Tertiary Centers.
Almeida R; Abrantes C; Gigliano D; Oliveira RC; Teixeira P; Viegas M; Rodrigues Â; Julião MJ
Int J Hematol Oncol Stem Cell Res; 2022 Apr; 16(2):94-102. PubMed ID: 36304730
[No Abstract] [Full Text] [Related]
18. A Literature Revision in Primary Cutaneous B-cell Lymphoma.
Selva R; Violetti SA; Delfino C; Grandi V; Cicchelli S; Tomasini C; Fierro MT; Berti E; Pimpinelli N; Quaglino P
Indian J Dermatol; 2017; 62(2):146-157. PubMed ID: 28400634
[TBL] [Abstract][Full Text] [Related]
19. IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers.
Verghese C; Li W; Gvazava N; Alimpertis E; Kahlon N; Sun H; Booth R
Clin Pathol; 2022; 15():2632010X221129242. PubMed ID: 36313587
[TBL] [Abstract][Full Text] [Related]
20. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
